Skip to main content
Article
Treatment of PCM1-JAK2 fusion tyrosine kinase gene-related acute lymphoblastic leukemia with stem cell transplantation
Future Rare Diseases (2021)
  • Henry G Kaplan, Swedish Cancer Institute, Seattle, WA 98104, USA
  • Carlo Bifulco, Medical Director, Medical Genomics, Providence St Joseph Health System, Portland, OR 97213, USA
  • Ruyun Jin, Center for Cardiovascular Analytics, Research & Data Science (CARDS), Providence Heart Institute, Providence St Joseph Health, Portland, OR 97225, USA
  • James M Scanlan, Swedish Center for Research & Innovation, Swedish Medical Center, Seattle, WA 98104, USA
  • David Colvin, Swedish Cancer Institute, Seattle, WA 98104, USA
Publication Date
June 1, 2021
DOI
10.2217/FRD-2021-0006
Citation Information
Henry G Kaplan, Carlo Bifulco, Ruyun Jin, James M Scanlan, et al.. "Treatment of PCM1-JAK2 fusion tyrosine kinase gene-related acute lymphoblastic leukemia with stem cell transplantation" Future Rare Diseases Vol. 1 Iss. 2 (2021)
Available at: http://works.bepress.com/carlo-bifulco/38/